Barclays analyst Michael Leithead upgraded Olin to Overweight from Equal Weight with a price target of $65, up from $60. Chlor-alkali supply/demand remains relatively tight, and the company’s shareholder remunerations "remain healthy and clearly-defined," Leithead tells investors in a research note. The analyst thinks Olin’s valuation underappreciates its "much-improved" free cash flow conversion and capital discipline.
Published first on TheFly
